Global Children Influenza Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
LPI (LP Information)' newest research report, the “Children Influenza Vaccine Industry Forecast” looks at past sales and reviews total world Children Influenza Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Children Influenza Vaccine sales for 2023 through 2029. With Children Influenza Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Children Influenza Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Children Influenza Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Children Influenza Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Children Influenza Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Children Influenza Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Children Influenza Vaccine.
The global Children Influenza Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Children Influenza Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Children Influenza Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Children Influenza Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Children Influenza Vaccine players cover Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca and CCBIO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Children Influenza Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Children Influenza Vaccine market?
What factors are driving Children Influenza Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Children Influenza Vaccine market opportunities vary by end market size?
How does Children Influenza Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
LPI (LP Information)' newest research report, the “Children Influenza Vaccine Industry Forecast” looks at past sales and reviews total world Children Influenza Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Children Influenza Vaccine sales for 2023 through 2029. With Children Influenza Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Children Influenza Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Children Influenza Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Children Influenza Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Children Influenza Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Children Influenza Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Children Influenza Vaccine.
The global Children Influenza Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Children Influenza Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Children Influenza Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Children Influenza Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Children Influenza Vaccine players cover Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca and CCBIO, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Children Influenza Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Nasal Spray
- Injection
- 6 Months to 3 Years
- Over 3 Years
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi Pasteur
- CSL
- GSK
- Mylan
- Hulan Bio
- AstraZeneca
- CCBIO
What is the 10-year outlook for the global Children Influenza Vaccine market?
What factors are driving Children Influenza Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Children Influenza Vaccine market opportunities vary by end market size?
How does Children Influenza Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Children Influenza Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Children Influenza Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Children Influenza Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Children Influenza Vaccine Segment by Type
2.2.1 Nasal Spray
2.2.2 Injection
2.3 Children Influenza Vaccine Sales by Type
2.3.1 Global Children Influenza Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Children Influenza Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Children Influenza Vaccine Sale Price by Type (2018-2023)
2.4 Children Influenza Vaccine Segment by Application
2.4.1 6 Months to 3 Years
2.4.2 Over 3 Years
2.5 Children Influenza Vaccine Sales by Application
2.5.1 Global Children Influenza Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Children Influenza Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Children Influenza Vaccine Sale Price by Application (2018-2023)
3 GLOBAL CHILDREN INFLUENZA VACCINE BY COMPANY
3.1 Global Children Influenza Vaccine Breakdown Data by Company
3.1.1 Global Children Influenza Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Children Influenza Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Children Influenza Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Children Influenza Vaccine Revenue by Company (2018-2023)
3.2.2 Global Children Influenza Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Children Influenza Vaccine Sale Price by Company
3.4 Key Manufacturers Children Influenza Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Children Influenza Vaccine Product Location Distribution
3.4.2 Players Children Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CHILDREN INFLUENZA VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Children Influenza Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Children Influenza Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Children Influenza Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Children Influenza Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Children Influenza Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Children Influenza Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Children Influenza Vaccine Sales Growth
4.4 APAC Children Influenza Vaccine Sales Growth
4.5 Europe Children Influenza Vaccine Sales Growth
4.6 Middle East & Africa Children Influenza Vaccine Sales Growth
5 AMERICAS
5.1 Americas Children Influenza Vaccine Sales by Country
5.1.1 Americas Children Influenza Vaccine Sales by Country (2018-2023)
5.1.2 Americas Children Influenza Vaccine Revenue by Country (2018-2023)
5.2 Americas Children Influenza Vaccine Sales by Type
5.3 Americas Children Influenza Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Children Influenza Vaccine Sales by Region
6.1.1 APAC Children Influenza Vaccine Sales by Region (2018-2023)
6.1.2 APAC Children Influenza Vaccine Revenue by Region (2018-2023)
6.2 APAC Children Influenza Vaccine Sales by Type
6.3 APAC Children Influenza Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Children Influenza Vaccine by Country
7.1.1 Europe Children Influenza Vaccine Sales by Country (2018-2023)
7.1.2 Europe Children Influenza Vaccine Revenue by Country (2018-2023)
7.2 Europe Children Influenza Vaccine Sales by Type
7.3 Europe Children Influenza Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Children Influenza Vaccine by Country
8.1.1 Middle East & Africa Children Influenza Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Children Influenza Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Children Influenza Vaccine Sales by Type
8.3 Middle East & Africa Children Influenza Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Children Influenza Vaccine
10.3 Manufacturing Process Analysis of Children Influenza Vaccine
10.4 Industry Chain Structure of Children Influenza Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Children Influenza Vaccine Distributors
11.3 Children Influenza Vaccine Customer
12 WORLD FORECAST REVIEW FOR CHILDREN INFLUENZA VACCINE BY GEOGRAPHIC REGION
12.1 Global Children Influenza Vaccine Market Size Forecast by Region
12.1.1 Global Children Influenza Vaccine Forecast by Region (2024-2029)
12.1.2 Global Children Influenza Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Children Influenza Vaccine Forecast by Type
12.7 Global Children Influenza Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Children Influenza Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Children Influenza Vaccine Product Portfolios and Specifications
13.2.3 CSL Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Children Influenza Vaccine Product Portfolios and Specifications
13.3.3 GSK Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Children Influenza Vaccine Product Portfolios and Specifications
13.4.3 Mylan Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 Hulan Bio
13.5.1 Hulan Bio Company Information
13.5.2 Hulan Bio Children Influenza Vaccine Product Portfolios and Specifications
13.5.3 Hulan Bio Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Hulan Bio Main Business Overview
13.5.5 Hulan Bio Latest Developments
13.6 AstraZeneca
13.6.1 AstraZeneca Company Information
13.6.2 AstraZeneca Children Influenza Vaccine Product Portfolios and Specifications
13.6.3 AstraZeneca Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 AstraZeneca Main Business Overview
13.6.5 AstraZeneca Latest Developments
13.7 CCBIO
13.7.1 CCBIO Company Information
13.7.2 CCBIO Children Influenza Vaccine Product Portfolios and Specifications
13.7.3 CCBIO Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 CCBIO Main Business Overview
13.7.5 CCBIO Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Children Influenza Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Children Influenza Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Children Influenza Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Children Influenza Vaccine Segment by Type
2.2.1 Nasal Spray
2.2.2 Injection
2.3 Children Influenza Vaccine Sales by Type
2.3.1 Global Children Influenza Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Children Influenza Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Children Influenza Vaccine Sale Price by Type (2018-2023)
2.4 Children Influenza Vaccine Segment by Application
2.4.1 6 Months to 3 Years
2.4.2 Over 3 Years
2.5 Children Influenza Vaccine Sales by Application
2.5.1 Global Children Influenza Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Children Influenza Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Children Influenza Vaccine Sale Price by Application (2018-2023)
3 GLOBAL CHILDREN INFLUENZA VACCINE BY COMPANY
3.1 Global Children Influenza Vaccine Breakdown Data by Company
3.1.1 Global Children Influenza Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Children Influenza Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Children Influenza Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Children Influenza Vaccine Revenue by Company (2018-2023)
3.2.2 Global Children Influenza Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Children Influenza Vaccine Sale Price by Company
3.4 Key Manufacturers Children Influenza Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Children Influenza Vaccine Product Location Distribution
3.4.2 Players Children Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CHILDREN INFLUENZA VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Children Influenza Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Children Influenza Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Children Influenza Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Children Influenza Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Children Influenza Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Children Influenza Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Children Influenza Vaccine Sales Growth
4.4 APAC Children Influenza Vaccine Sales Growth
4.5 Europe Children Influenza Vaccine Sales Growth
4.6 Middle East & Africa Children Influenza Vaccine Sales Growth
5 AMERICAS
5.1 Americas Children Influenza Vaccine Sales by Country
5.1.1 Americas Children Influenza Vaccine Sales by Country (2018-2023)
5.1.2 Americas Children Influenza Vaccine Revenue by Country (2018-2023)
5.2 Americas Children Influenza Vaccine Sales by Type
5.3 Americas Children Influenza Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Children Influenza Vaccine Sales by Region
6.1.1 APAC Children Influenza Vaccine Sales by Region (2018-2023)
6.1.2 APAC Children Influenza Vaccine Revenue by Region (2018-2023)
6.2 APAC Children Influenza Vaccine Sales by Type
6.3 APAC Children Influenza Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Children Influenza Vaccine by Country
7.1.1 Europe Children Influenza Vaccine Sales by Country (2018-2023)
7.1.2 Europe Children Influenza Vaccine Revenue by Country (2018-2023)
7.2 Europe Children Influenza Vaccine Sales by Type
7.3 Europe Children Influenza Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Children Influenza Vaccine by Country
8.1.1 Middle East & Africa Children Influenza Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Children Influenza Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Children Influenza Vaccine Sales by Type
8.3 Middle East & Africa Children Influenza Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Children Influenza Vaccine
10.3 Manufacturing Process Analysis of Children Influenza Vaccine
10.4 Industry Chain Structure of Children Influenza Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Children Influenza Vaccine Distributors
11.3 Children Influenza Vaccine Customer
12 WORLD FORECAST REVIEW FOR CHILDREN INFLUENZA VACCINE BY GEOGRAPHIC REGION
12.1 Global Children Influenza Vaccine Market Size Forecast by Region
12.1.1 Global Children Influenza Vaccine Forecast by Region (2024-2029)
12.1.2 Global Children Influenza Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Children Influenza Vaccine Forecast by Type
12.7 Global Children Influenza Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi Pasteur
13.1.1 Sanofi Pasteur Company Information
13.1.2 Sanofi Pasteur Children Influenza Vaccine Product Portfolios and Specifications
13.1.3 Sanofi Pasteur Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Sanofi Pasteur Main Business Overview
13.1.5 Sanofi Pasteur Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Children Influenza Vaccine Product Portfolios and Specifications
13.2.3 CSL Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Children Influenza Vaccine Product Portfolios and Specifications
13.3.3 GSK Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Children Influenza Vaccine Product Portfolios and Specifications
13.4.3 Mylan Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 Hulan Bio
13.5.1 Hulan Bio Company Information
13.5.2 Hulan Bio Children Influenza Vaccine Product Portfolios and Specifications
13.5.3 Hulan Bio Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Hulan Bio Main Business Overview
13.5.5 Hulan Bio Latest Developments
13.6 AstraZeneca
13.6.1 AstraZeneca Company Information
13.6.2 AstraZeneca Children Influenza Vaccine Product Portfolios and Specifications
13.6.3 AstraZeneca Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 AstraZeneca Main Business Overview
13.6.5 AstraZeneca Latest Developments
13.7 CCBIO
13.7.1 CCBIO Company Information
13.7.2 CCBIO Children Influenza Vaccine Product Portfolios and Specifications
13.7.3 CCBIO Children Influenza Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 CCBIO Main Business Overview
13.7.5 CCBIO Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Children Influenza Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Children Influenza Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Nasal Spray
Table 4. Major Players of Injection
Table 5. Global Children Influenza Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Children Influenza Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Children Influenza Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Children Influenza Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Children Influenza Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Children Influenza Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Children Influenza Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Children Influenza Vaccine Revenue by Application (2018-2023)
Table 13. Global Children Influenza Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Children Influenza Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Children Influenza Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Children Influenza Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Children Influenza Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Children Influenza Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Children Influenza Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Children Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Children Influenza Vaccine Products Offered
Table 22. Children Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Children Influenza Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Children Influenza Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Children Influenza Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Children Influenza Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Children Influenza Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Children Influenza Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Children Influenza Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Children Influenza Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Children Influenza Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Children Influenza Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Children Influenza Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Children Influenza Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Children Influenza Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Children Influenza Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Children Influenza Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Children Influenza Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Children Influenza Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Children Influenza Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Children Influenza Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Children Influenza Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Children Influenza Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Children Influenza Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Children Influenza Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Children Influenza Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Children Influenza Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Children Influenza Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Children Influenza Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Children Influenza Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Children Influenza Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Children Influenza Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Children Influenza Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Children Influenza Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Children Influenza Vaccine
Table 58. Key Market Challenges & Risks of Children Influenza Vaccine
Table 59. Key Industry Trends of Children Influenza Vaccine
Table 60. Children Influenza Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Children Influenza Vaccine Distributors List
Table 63. Children Influenza Vaccine Customer List
Table 64. Global Children Influenza Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Children Influenza Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Children Influenza Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Children Influenza Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Children Influenza Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Children Influenza Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Children Influenza Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Children Influenza Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Children Influenza Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Children Influenza Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Children Influenza Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Children Influenza Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Children Influenza Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Children Influenza Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sanofi Pasteur Basic Information, Children Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Pasteur Children Influenza Vaccine Product Portfolios and Specifications
Table 80. Sanofi Pasteur Children Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Sanofi Pasteur Main Business
Table 82. Sanofi Pasteur Latest Developments
Table 83. CSL Basic Information, Children Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Children Influenza Vaccine Product Portfolios and Specifications
Table 85. CSL Children Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. CSL Main Business
Table 87. CSL Latest Developments
Table 88. GSK Basic Information, Children Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. GSK Children Influenza Vaccine Product Portfolios and Specifications
Table 90. GSK Children Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. GSK Main Business
Table 92. GSK Latest Developments
Table 93. Mylan Basic Information, Children Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Mylan Children Influenza Vaccine Product Portfolios and Specifications
Table 95. Mylan Children Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Mylan Main Business
Table 97. Mylan Latest Developments
Table 98. Hulan Bio Basic Information, Children Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Hulan Bio Children Influenza Vaccine Product Portfolios and Specifications
Table 100. Hulan Bio Children Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Hulan Bio Main Business
Table 102. Hulan Bio Latest Developments
Table 103. AstraZeneca Basic Information, Children Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. AstraZeneca Children Influenza Vaccine Product Portfolios and Specifications
Table 105. AstraZeneca Children Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. AstraZeneca Main Business
Table 107. AstraZeneca Latest Developments
Table 108. CCBIO Basic Information, Children Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. CCBIO Children Influenza Vaccine Product Portfolios and Specifications
Table 110. CCBIO Children Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. CCBIO Main Business
Table 112. CCBIO Latest Developments
Table 1. Children Influenza Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Children Influenza Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Nasal Spray
Table 4. Major Players of Injection
Table 5. Global Children Influenza Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Children Influenza Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Children Influenza Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Children Influenza Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Children Influenza Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Children Influenza Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Children Influenza Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Children Influenza Vaccine Revenue by Application (2018-2023)
Table 13. Global Children Influenza Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Children Influenza Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Children Influenza Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Children Influenza Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Children Influenza Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Children Influenza Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Children Influenza Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Children Influenza Vaccine Producing Area Distribution and Sales Area
Table 21. Players Children Influenza Vaccine Products Offered
Table 22. Children Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Children Influenza Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Children Influenza Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Children Influenza Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Children Influenza Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Children Influenza Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Children Influenza Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Children Influenza Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Children Influenza Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Children Influenza Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Children Influenza Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Children Influenza Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Children Influenza Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Children Influenza Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Children Influenza Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Children Influenza Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Children Influenza Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Children Influenza Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Children Influenza Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Children Influenza Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Children Influenza Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Children Influenza Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Children Influenza Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Children Influenza Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Children Influenza Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Children Influenza Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Children Influenza Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Children Influenza Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Children Influenza Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Children Influenza Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Children Influenza Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Children Influenza Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Children Influenza Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Children Influenza Vaccine
Table 58. Key Market Challenges & Risks of Children Influenza Vaccine
Table 59. Key Industry Trends of Children Influenza Vaccine
Table 60. Children Influenza Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Children Influenza Vaccine Distributors List
Table 63. Children Influenza Vaccine Customer List
Table 64. Global Children Influenza Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Children Influenza Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Children Influenza Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Children Influenza Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Children Influenza Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Children Influenza Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Children Influenza Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Children Influenza Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Children Influenza Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Children Influenza Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Children Influenza Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Children Influenza Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Children Influenza Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Children Influenza Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sanofi Pasteur Basic Information, Children Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Pasteur Children Influenza Vaccine Product Portfolios and Specifications
Table 80. Sanofi Pasteur Children Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Sanofi Pasteur Main Business
Table 82. Sanofi Pasteur Latest Developments
Table 83. CSL Basic Information, Children Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Children Influenza Vaccine Product Portfolios and Specifications
Table 85. CSL Children Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. CSL Main Business
Table 87. CSL Latest Developments
Table 88. GSK Basic Information, Children Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. GSK Children Influenza Vaccine Product Portfolios and Specifications
Table 90. GSK Children Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. GSK Main Business
Table 92. GSK Latest Developments
Table 93. Mylan Basic Information, Children Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Mylan Children Influenza Vaccine Product Portfolios and Specifications
Table 95. Mylan Children Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Mylan Main Business
Table 97. Mylan Latest Developments
Table 98. Hulan Bio Basic Information, Children Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Hulan Bio Children Influenza Vaccine Product Portfolios and Specifications
Table 100. Hulan Bio Children Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Hulan Bio Main Business
Table 102. Hulan Bio Latest Developments
Table 103. AstraZeneca Basic Information, Children Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. AstraZeneca Children Influenza Vaccine Product Portfolios and Specifications
Table 105. AstraZeneca Children Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. AstraZeneca Main Business
Table 107. AstraZeneca Latest Developments
Table 108. CCBIO Basic Information, Children Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. CCBIO Children Influenza Vaccine Product Portfolios and Specifications
Table 110. CCBIO Children Influenza Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. CCBIO Main Business
Table 112. CCBIO Latest Developments
LIST OF FIGURES
Figure 1. Picture of Children Influenza Vaccine
Figure 2. Children Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Children Influenza Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Children Influenza Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Children Influenza Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Nasal Spray
Figure 10. Product Picture of Injection
Figure 11. Global Children Influenza Vaccine Sales Market Share by Type in 2022
Figure 12. Global Children Influenza Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Children Influenza Vaccine Consumed in 6 Months to 3 Years
Figure 14. Global Children Influenza Vaccine Market: 6 Months to 3 Years (2018-2023) & (K Units)
Figure 15. Children Influenza Vaccine Consumed in Over 3 Years
Figure 16. Global Children Influenza Vaccine Market: Over 3 Years (2018-2023) & (K Units)
Figure 17. Global Children Influenza Vaccine Sales Market Share by Application (2022)
Figure 18. Global Children Influenza Vaccine Revenue Market Share by Application in 2022
Figure 19. Children Influenza Vaccine Sales Market by Company in 2022 (K Units)
Figure 20. Global Children Influenza Vaccine Sales Market Share by Company in 2022
Figure 21. Children Influenza Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Children Influenza Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Children Influenza Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Children Influenza Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Children Influenza Vaccine Sales 2018-2023 (K Units)
Figure 26. Americas Children Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Children Influenza Vaccine Sales 2018-2023 (K Units)
Figure 28. APAC Children Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Children Influenza Vaccine Sales 2018-2023 (K Units)
Figure 30. Europe Children Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Children Influenza Vaccine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Children Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Children Influenza Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Children Influenza Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Children Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Children Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Children Influenza Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Children Influenza Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Children Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Children Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Children Influenza Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Children Influenza Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Children Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Children Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Children Influenza Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Children Influenza Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Children Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Children Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Children Influenza Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Children Influenza Vaccine
Figure 72. Industry Chain Structure of Children Influenza Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Children Influenza Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Children Influenza Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Children Influenza Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Children Influenza Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Children Influenza Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Children Influenza Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Children Influenza Vaccine
Figure 2. Children Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Children Influenza Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Children Influenza Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Children Influenza Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Nasal Spray
Figure 10. Product Picture of Injection
Figure 11. Global Children Influenza Vaccine Sales Market Share by Type in 2022
Figure 12. Global Children Influenza Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Children Influenza Vaccine Consumed in 6 Months to 3 Years
Figure 14. Global Children Influenza Vaccine Market: 6 Months to 3 Years (2018-2023) & (K Units)
Figure 15. Children Influenza Vaccine Consumed in Over 3 Years
Figure 16. Global Children Influenza Vaccine Market: Over 3 Years (2018-2023) & (K Units)
Figure 17. Global Children Influenza Vaccine Sales Market Share by Application (2022)
Figure 18. Global Children Influenza Vaccine Revenue Market Share by Application in 2022
Figure 19. Children Influenza Vaccine Sales Market by Company in 2022 (K Units)
Figure 20. Global Children Influenza Vaccine Sales Market Share by Company in 2022
Figure 21. Children Influenza Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Children Influenza Vaccine Revenue Market Share by Company in 2022
Figure 23. Global Children Influenza Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Children Influenza Vaccine Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Children Influenza Vaccine Sales 2018-2023 (K Units)
Figure 26. Americas Children Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 27. APAC Children Influenza Vaccine Sales 2018-2023 (K Units)
Figure 28. APAC Children Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. Europe Children Influenza Vaccine Sales 2018-2023 (K Units)
Figure 30. Europe Children Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Children Influenza Vaccine Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Children Influenza Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Americas Children Influenza Vaccine Sales Market Share by Country in 2022
Figure 34. Americas Children Influenza Vaccine Revenue Market Share by Country in 2022
Figure 35. Americas Children Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 36. Americas Children Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 37. United States Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Children Influenza Vaccine Sales Market Share by Region in 2022
Figure 42. APAC Children Influenza Vaccine Revenue Market Share by Regions in 2022
Figure 43. APAC Children Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 44. APAC Children Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 45. China Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Children Influenza Vaccine Sales Market Share by Country in 2022
Figure 53. Europe Children Influenza Vaccine Revenue Market Share by Country in 2022
Figure 54. Europe Children Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 55. Europe Children Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 56. Germany Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Children Influenza Vaccine Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Children Influenza Vaccine Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Children Influenza Vaccine Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Children Influenza Vaccine Sales Market Share by Application (2018-2023)
Figure 65. Egypt Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Children Influenza Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Children Influenza Vaccine in 2022
Figure 71. Manufacturing Process Analysis of Children Influenza Vaccine
Figure 72. Industry Chain Structure of Children Influenza Vaccine
Figure 73. Channels of Distribution
Figure 74. Global Children Influenza Vaccine Sales Market Forecast by Region (2024-2029)
Figure 75. Global Children Influenza Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Children Influenza Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Children Influenza Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Children Influenza Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Children Influenza Vaccine Revenue Market Share Forecast by Application (2024-2029)
